- Home
- JOB vs ENLV Comparison
JOB vs ENLV Comparison
Compare JOB & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JOB | ENLV |
|---|---|---|
| Founded | 1893 | 2005 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.2M | 196.2M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | JOB | ENLV |
|---|---|---|
| Price | $0.23 | $0.72 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | ★ 264.3K | 248.6K |
| Earning Date | 05-14-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | N/A |
| Revenue | ★ $96,504,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.17 | $0.66 |
| 52 Week High | $0.28 | $2.10 |
Technical Indicators
Market Signals| Indicator | JOB | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 46.02 | 35.33 |
| Support Level | $0.22 | $0.66 |
| Resistance Level | $0.27 | $1.25 |
| Average True Range (ATR) | 0.01 | 0.05 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 14.66 | 14.38 |
Price Performance
Historical ComparisonAbout JOB GEE Group Inc.
GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.